not losing weight on semaglutide should i switch to tirzepatide Semaglutide & Tirzepatide Long Beach CA Why am I not losing

As of late 2025, it is not yet FDA-approved

In a study published in The Journal of Clinical Endocrinology & Metabolism , Tesamorelin elevated IGF-1 levels within 2 weeks of administration, confirming its efficacy in stimulating GH pathways (Gelato et al., 2004)

Dosage and Administration of IGF-1 LR3 Typical Dosage Guidelines When it comes to dosing IGF-1 LR3, precision and individualization are essential

Nutrition therapy and clinical nutrition approaches are especially valuable for people on Ozempic, as they provide evidence-based strategies to optimize health outcomes and manage side effects

Yang D, Mu Y, Wang J, Zou W, Zou H, Yang H, et al